Early Phase 1 Neovascular Age-related Macular Degeneration Clinical Trials
2 recruitingEarly Phase 1
What is a Early Phase 1 trial?
Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.
Showing 1–2 of 2 trials
Recruiting
Early Phase 1
Safety and Efficacy Evaluation of LX111 Gene Therapy in nAMD Patients
Neovascular Age-related Macular Degeneration
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine10 enrolled1 locationNCT07053358
Recruiting
Early Phase 1
CRISPR/cas13-medIated RNA TarGeting THerapy for the Treatment of Neovascular Age-related Macular Degeneration Investigator-initiated Trial (SIGHT-I)
Neovascular Age-Related Macular Degeneration (nAMD)
HuidaGene Therapeutics Co., Ltd.12 enrolled2 locationsNCT06031727